BUZZ-BioCardia says FDA has cleared company to market its device, shares rise
I'm PortAI, I can summarize articles.
Shares of BioCardiarise 92.73% to $4.24, after the bellThe U.S. FDA has cleared company to market its device, subject to the general controls provisions of the Federal Food, Drug and Cosmetic Act, a filing shows The Morph DNA steerable introducer product is intended to provide a pathway through which medical instruments such as balloon dilatation catheters, guidewires, or other therapeutic devices may be introduced into the peripheral vasculature or chambers and coronary vasculature of the heart - BCDAStock down ~78% YTD
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments